Biomedical Engineering Reference
In-Depth Information
19. Kerbel RS, Cornil I, Korczak, B. 1989. New insights into the evolutionary growth of tumors
revealed by southern gel analysis of tumors genetically tagged with plasmid or proviral DNA
insertions.
J Cell Sci
94
:381-387.
20. MacPhee DG. 1991. The significance of deletions in spontaneous and induced mutations asso-
ciated with movement of transposable DNA elements: possible implications for evolution and
cancer.
Mutation Res
250
:35-47.
21. Yuan J, Narayanan L, Rockwell S, Glazer PM. 2000. Diminished DNA repair and elevated
mutagenesis in mammalian cells exposed to hypoxia and low pH.
Cancer Res
60
:4372-4376.
22. Reynolds TY, Rockwell S, Glazer PM. 1996. Genetic instability induced by the tumor micro-
environment.
Cancer Res
56
:5754-5757.
23. Coffey DS, Isaacs JT. 1981. Prostate tumor biology and cell kinetics-theory.
Urology
17
(suppl):40-53.
24. Hussein MR, Haemel AK, Wood GS. 2003. Apoptosis and melanoma: molecular mechanisms.
J Pathol
199
:275-288.
25. Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ, Grossman D. 2003. Apoptosis
regulators and responses in human melanocytic and keratinocytic cells.
J Invest Dermatol
120
:18-55.
26. Hoglund M, Gisselsson D, Hansen GB, Sall T, Mitelman F. 2002. Multivariate analysis of
chromosomal imbalances in breast cancer delineates cytogenetic pathways and reveals com-
plex relationships among imbalances.
Cancer Res
62
:2675-2680.
27. Abraham S, Zhang W, Greenberg N, Zhang M. 2003. Maspin functions as tumor suppressor by
increasing cell adhesion to extracellular matrix in prostate tumor cells.
J Urol
169
:1157-1161.
28. Su ZZ, Gopalkrishnan RV, Narayan G, Dent P, Fisher PB. 2002. Progression elevated gene-3,
PEG-3, induces genomic instability in rodent and human tumor cells.
J Cell Physiol
192
:34-
44.
29. Kondoh N, Shuda M, Arai M, Oikawa T, Yamamoto M. 1988. Activation of anchorage-
independent growth of HT1080 human fibroblasts.
Mutat Res
199
:273-291.
30. Cooper CR, Chay CH, Gendernalik JD, Lee HL, Bhatia J, Taichman RS, McCauley LK, Keller
ET, Pienta KJ. 2003. Stromal factors involved in prostate carcinoma metastasis to bone.
Can-
cer
97
:739-747.
31. Folkman J. 2002. Role of angiogenesis in tumor growth and metastasis.
Semin Oncol
29
:15-
18.
32. van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW. 2003. Involvement
of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in
vitro.
Arterioscler Thromb Vasc Biol
23
:211-217.
33. Chang L, Kaipainen A, Folkman J. 2002. Lymphangiogenesis new mechanisms.
Ann NY Acad
Sci
979
:111-119.
34. Chung AS, Yoon SO, Park SJ, Yun CH. 2003. Roles of matrix metalloproteinases in tumor
metastasis and angiogenesis.
J Biochem Mol Biol
36
(1):128-137.
35. Nambu Y, Beer DG. 2003. Altered surface markers in lung cancer: lack of cell-surface
Fas/APO-1 expression in pulmonary adenocarcinoma may allow escape from immune surveil-
lance.
Methods Mol Med
74
:259-266.
36. Ivanovic VV, Todorovic-Rakovic N, Demajo M, Neskovic-Konstantinovic Z, Subota V,
Ivanisevic-Milovanovic O, Nikolic-Vukosavljevic D. 2002. Elevated plasma levels of trans-
forming growth factor-beta(1) (TGF-beta(1)) in patients with advanced breast cancer: associa-
tion with disease progression.
Eur J Cancer
39
:454-461.
37.
Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. 2001.
Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.
Cancer Metastasis
Rev
20:333-349.
38.
Rossi MC, Zetter BR. 1992. Selective stimulation of prostatic carcinoma cell proliferation by
transferrin.
Proc Natl Acad Sci USA
89
:6197-6201.
